A detailed history of Oregon Public Employees Retirement Fund transactions in Myriad Genetics Inc stock. As of the latest transaction made, Oregon Public Employees Retirement Fund holds 21,422 shares of MYGN stock, worth $326,685. This represents 0.01% of its overall portfolio holdings.

Number of Shares
21,422
Previous 21,922 2.28%
Holding current value
$326,685
Previous $536,000 9.33%
% of portfolio
0.01%
Previous 0.01%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

SELL
$23.97 - $28.6 $11,985 - $14,300
-500 Reduced 2.28%
21,422 $586,000
Q2 2024

Aug 01, 2024

SELL
$17.98 - $25.47 $31,321 - $44,368
-1,742 Reduced 7.36%
21,922 $536,000
Q1 2024

May 02, 2024

SELL
$17.59 - $23.59 $40,457 - $54,257
-2,300 Reduced 8.86%
23,664 $504,000
Q4 2023

Feb 12, 2024

BUY
$13.91 - $21.32 $22,256 - $34,112
1,600 Added 6.57%
25,964 $496,000
Q3 2023

Oct 26, 2023

SELL
$15.99 - $23.22 $17,589 - $25,542
-1,100 Reduced 4.32%
24,364 $390,000
Q2 2023

Jul 26, 2023

SELL
$17.56 - $23.76 $10,536 - $14,256
-600 Reduced 2.3%
25,464 $590,000
Q1 2023

May 04, 2023

SELL
$15.26 - $23.75 $13,276 - $20,662
-870 Reduced 3.23%
26,064 $605,000
Q4 2022

Jan 26, 2023

BUY
$14.51 - $20.99 $5,963 - $8,626
411 Added 1.55%
26,934 $0
Q3 2022

Nov 01, 2022

BUY
$18.21 - $27.88 $3,241 - $4,962
178 Added 0.68%
26,523 $506,000
Q2 2022

Jul 25, 2022

SELL
$16.45 - $25.88 $62,230 - $97,904
-3,783 Reduced 12.56%
26,345 $479,000
Q1 2022

Apr 21, 2022

BUY
$22.67 - $28.01 $3,151 - $3,893
139 Added 0.46%
30,128 $759,000
Q4 2021

Feb 01, 2022

SELL
$24.13 - $32.63 $33,782 - $45,682
-1,400 Reduced 4.46%
29,989 $828,000
Q3 2021

Oct 19, 2021

BUY
$29.97 - $36.66 $19,240 - $23,535
642 Added 2.09%
31,389 $1.01 Million
Q1 2021

Apr 20, 2021

BUY
$19.92 - $31.6 $11,952 - $18,960
600 Added 1.99%
30,747 $936,000
Q4 2020

Feb 09, 2021

BUY
$12.16 - $19.77 $3,806 - $6,188
313 Added 1.05%
30,147 $596,000
Q4 2019

Feb 05, 2020

BUY
$20.93 - $35.1 $14,651 - $24,570
700 Added 2.4%
29,834 $812,000
Q3 2019

Nov 07, 2019

BUY
$22.08 - $47.08 $2,208 - $4,708
100 Added 0.34%
29,134 $834,000
Q2 2019

Jul 16, 2019

BUY
$22.67 - $35.0 $1,790 - $2,765
79 Added 0.27%
29,034 $807,000
Q1 2019

May 07, 2019

BUY
$26.93 - $34.7 $14,084 - $18,148
523 Added 1.84%
28,955 $961,000
Q4 2018

Feb 07, 2019

SELL
$27.23 - $45.56 $21.7 Million - $36.4 Million
-798,086 Reduced 96.56%
28,432 $827,000
Q4 2018

Feb 05, 2019

BUY
$27.23 - $45.56 $22.5 Million - $37.7 Million
826,518 New
826,518 $28,000

Others Institutions Holding MYGN

About MYRIAD GENETICS INC


  • Ticker MYGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 80,634,800
  • Market Cap $1.23B
  • Description
  • Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...
More about MYGN
Track This Portfolio

Track Oregon Public Employees Retirement Fund Portfolio

Follow Oregon Public Employees Retirement Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oregon Public Employees Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on Oregon Public Employees Retirement Fund with notifications on news.